Hemodialysis outcome associated with basilic vein transposition or synthetic vascular grafting: a single-center study

Authors

  • A.M. Fahad Najaf Health Directorate, Najaf, Iraq https://orcid.org/0000-0003-2810-2810
  • H.N. Naser Najaf Health Directorate, Najaf, Iraq
  • L.F.F. Sharba Jabir Ibn Hayyan Medical University, Najaf, Iraq https://orcid.org/0000-0002-2206-705X
  • H.S.K. Al-Shakarchi Najaf Health Directorate, Najaf, Iraq
  • Z.A. Yasser Najaf Health Directorate, Najaf, Iraq
  • A.A. Abed Najaf Health Directorate, Najaf, Iraq

DOI:

https://doi.org/10.22141/2307-1257.14.1.2025.504

Keywords:

hemodialysis, basilic vein, synthetic graft, chronic kidney disease

Abstract

Background. For hemodialysis, an autogenous radiocephalic or brachiocephalic fistula is the preferred types of vascular access, while basilic vein transposition (BVT) fistula followed by prosthetic grafting is suggested if unsuitable veins are present. The purpose was to compare the outcome of BVT versus synthetic vascular graft used for dialysis in a single centre. Materials and methods. This study includes total of 148 patients that subdivided into two groups: group one (n = 127; 69 male and 58 female patients, mean age 49 years) operated with BVT and group two (n = 21; 15 male and 6 female individuals, mean age 58 years) operated with synthetic vascular graft. Results. Seven patients with hematoma were treated with exploration within 7 days of operation (p = 0.001). Venous hypertension was present in 3 patients of group one and no patient in group two (p = 0.001). In group one, the complication rate was 13.38 %, while in group two, it was 28.57 % with statistically significant difference (p = 0.001). In group one, primary patency rate is 96.85 versus 90.47 % in group two (p = 0.07). The assisted primary in group one was 75 % versus no patient assisted in group two (p = 0.001). Conclusions. This study concludes that use of synthetic graft for dialysis is associated with more complications regarding thrombosis rate, ischemic steal syndrome and infection rate compared to using the basilic vein. In addition to that, the successful rate of embolectomy was low with synthetic graft use.

Downloads

Download data is not yet available.

References

Segura-Orti E, Koufaki P, Kouidi E. Bridging the gap from research to practice for enhanced health-related quality of life in people with chronic kidney disease. Clin Kidney J. 2021 May 6;14(Suppl 2):ii34-ii42. doi: 10.1093/ckj/sfaa268.

Kakkos SK, Lampropoulos GC, Nikolakopoulos KM, et al. A Systematic Review and Meta-Analysis of Randomized Trials Comparing Two-Stage with One-Stage Brachio-Basilic Vein Fistulas. Vasc Specialist Int. 2018 Sep;34(3):51-60. doi: 10.5758/vsi.2018.34.3.51.

Noori N, Sharma Parpia A, Wald R, Goldstein MB. Validation of the SMH Equations for the Estimation of the Total Body Water Volume in Hemodialysis Patients. Can J Kidney Health Dis. 2022 Nov 22;9:20543581221137180. doi: 10.1177/20543581221137180.

Porazko T, Piersiak A, Klinger M. The efficacy of single suture for exit site wound closure and stabilization of hemodialysis central tunneled catheter. SAGE Open Med. 2021 May 28;9:20503121211019889. doi: 10.1177/20503121211019889.

Almhanni G, Sen I, Vang S, et al. Midterm outcomes of endoscopic-assisted brachial-basilic arteriovenous fistula creation. J Vasc Surg Cases Innov Tech. 2023 Nov 26;10(2):101382. doi: 10.1016/j.jvscit.2023.101382.

Lu Y, Xiao J, Liu C, Wang Y. Comparison of wound complications between one-stage and two-stage brachiobasilic arteriovenous fistula: A meta-analysis. Int Wound J. 2023 Nov;20(9):3786-3793. doi: 10.1111/iwj.14278.

Li H, Jen S, Ramayya T, Bowers HG, Rotem E. Unanticipated late maturation of an arteriovenous fistula after creation of separate graft access. Quant Imaging Med Surg. 2018 May;8(4):444-446. doi: 10.21037/qims.2018.01.03.

Al Shakarchi J, Houston G, Inston N. Early cannulation grafts for haemodialysis: a systematic review. J Vasc Access. 2015 Nov-Dec;16(6):493-497. doi: 10.5301/jva.5000412.

Tanner NC, Da Silva A. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Cochrane Database Syst Rev. 2015;7:CD002786. doi: 10.1002/14651858.CD002786.pub3.

Migliori M, Cantaluppi V, Scatena A, Panichi V. Antiplatelet agents in hemodialysis. J Nephrol. 2017 Jun;30(3):373-383. doi: 10.1007/s40620-016-0367-5.

Iglesias R, Lodi M, Rubiella C, Teresa Parisotto M, Ibeas J. Ultrasound guided cannulation of dialysis access. J Vasc Access. 2021 Nov;22(Suppl 1):106-112. doi: 10.1177/11297298211047328.

Kaller R, Russu E, Arbănași EM, et al. Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients. J Clin Med. 2023 Jun 30;12(13):4419. doi: 10.3390/jcm12134419.

Deguchi J, Sato O. Transposed Brachial-Basilic Arteriovenous Fistula for Vascular Access in Japan. Ann Vasc Dis. 2018 Jun 25;11(2):181-190. doi: 10.3400/avd.ra.18-00009.

Patel RJ, Willie-Permor D, Zarrintan S, Elsayed N, Al-Nouri O, Malas MB. Two-Stage Offers No Advantages over Single-Stage Arteriovenous Creation: An Analysis of Multicenter National Data. Ann Vasc Surg. 2023 Oct;96:308-315. doi: 10.1016/j.avsg.2023.03.020.

Kakkos SK, Tsolakis IA, Papadoulas SI, et al. Randomized controlled trial comparing primary and staged basilic vein transposition. Front Surg. 2015 Apr 29;2:14. doi: 10.3389/fsurg.2015.00014.

Sadasivan K, Kunjuraman U, Murali B, Yadev I, Kochunarayanan A. Factors Affecting the Patency of Radiocephalic Arteriovenous Fistulas Based on Clinico-Radiological Parameters. Cureus. 2021 Mar 3;13(3):e13678. doi: 10.7759/cureus.13678.

Sadeghi A, Setayesh Mehr M, Esfandiari E, Mohammadi S, Baharmian H. Variation of the cephalic and basilic veins: A case report. J Cardiovasc Thorac Res. 2017;9(4):232-234. doi: 10.15171/jcvtr.2017.40.

Van Dellen D, Junejo M, Khambalia H, Campbell B. Transposition of brachiobasilic arteriovenous fistulae: improving the cosmetic effect without compromising patency. Ann R Coll Surg Engl. 2016 Jan;98(1):24-28. doi: 10.1308/003588414X14055925061757.

Laranjinha I, Matias P, Azevedo A, et al. Are high flow arteriovenous accesses associated with worse haemodialysis? J Bras Nefrol. 2018 Apr-Jun;40(2):136-142. doi: 10.1590/2175-8239-JBN-3875.

Moosa MA, Shaikh FA, Ali M, Salam A, Sophie Z, Siddiqui N. Comparison of Upper Limb Translocated Femoral Vein and Prosthetic Arteriovenous Bridge Grafts. Cureus. 2019 Nov 22;11(11):e6219. doi: 10.7759/cureus.6219.

Xiao Y, Vazquez-Padron RI, Martinez L, Singer HA, Woltmann D, Salman LH. Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far? J Vasc Access. 2024 Mar;25(2):390-406. doi: 10.1177/11297298221085458.

Jairath A, Singh A, Sabnis R, Ganpule A, Desai M. Minimally invasive basilic vein transposition in the arm or forearm for autogenous haemodialysis access: A less morbid alternative to the conventional technique. Arab J Urol. 2017 Mar 6;15(2):170-176. doi: 10.1016/j.aju.2017.01.004.

Jeong H, Bae M, Chung SW, Lee CW, Huh U, Kim MS. Videoscopic Surgery for Arteriovenous Hemodialysis Access. Korean J Thorac Cardiovasc Surg. 2020 Feb;53(1):28-33. doi: 10.5090/kjtcs.2020.53.1.28.

Kahraman N, Demir D. Outcomes of arteriovenous fistula reconstruction in vascular access dysfunction. Am J Transl Res. 2019 Feb 15;11(2):1058-1065.

Saroukhani A, Rafiee Zadeh A, Ahmadi SM. Incidence of steal syndrome following arteriovenous fistula and arteriovenous graft. Int J Burns Trauma. 2022 Jun 15;12(3):121-126.

Lookstein RA, Haruguchi H, Ouriel K, et al.; IN.PACT AV Access Investigators. Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. N Engl J Med. 2020 Aug 20;383(8):733-742. doi: 10.1056/NEJMoa1914617.

Karaca OG, Basal AN, Ecevit AN, Kalender M, Darcin OT, Sungur MA. Radiobasilic Versus Brachiobasilic Transposition on the Upper Arm to Avoid Steal Syndrome. Med Sci Monit. 2015 Dec 29;21:4090-4095. doi: 10.12659/msm.896642.

Sepas HN, Negahi A, Mousavie SH, Vosough F, Farazmand B. Patency and outcomes of tunneled hemodialysis catheter via femoral versus jugular vein access. J Adv Pharm Technol Res. 2019 Apr-Jun;10(2):81-84. doi: 10.4103/japtr.JAPTR_383_18.

Solanki PB. Autologous vein graft in living donor kidney transplant (case report). Kidneys. 2024;13(2):172-174. doi: 10.22141/2307-1257.13.2.2024.457.

Ivanova MD. The role of levocarnitine in the systemic therapy of patients of different profile of patients on chronic hemodialysis. Kidneys. 2014;(1):81-84. Ukrainian. doi: 10.22141/2307-1257.0.1.07.2014.76553.

Downloads

Published

2025-03-25

How to Cite

Fahad, A., Naser, H., Sharba, L., Al-Shakarchi, H., Yasser, Z., & Abed, A. (2025). Hemodialysis outcome associated with basilic vein transposition or synthetic vascular grafting: a single-center study. KIDNEYS, 14(1), 51–56. https://doi.org/10.22141/2307-1257.14.1.2025.504

Issue

Section

Original Articles